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Airway hyperresponsiveness (AHR), a characteristic of asthma that involves an excessive
reduction in airway caliber, is a complexmechanism reﬂectingmultiple processes thatman-
ifest over a large range of length and time scales. At one extreme, molecular interactions
determine the force generated by airway smooth muscle (ASM). At the other, the spatially
distributed constriction of the branching airways leads to breathing difﬁculties. Similarly,
asthma therapies act at the molecular scale while clinical outcomes are determined by
lung function. These extremes are linked by events operating over intermediate scales of
length and time. Thus, AHR is an emergent phenomenon that limits our understanding
of asthma and confounds the interpretation of studies that address physiological mech-
anisms over a limited range of scales. A solution is a modular computational model that
integrates experimental and mathematical data from multiple scales. This includes, at the
molecular scale, kinetics, and force production of actin-myosin contractile proteins during
cross-bridge and latch-state cycling; at the cellular scale, Ca2+ signaling mechanisms that
regulate ASM force production; at the tissue scale, forces acting between contracting ASM
and opposing viscoelastic tissue that determine airway narrowing; at the organ scale, the
topographic distribution of ASM contraction dynamics that determine mechanical imped-
ance of the lung. At each scale, models are constructed with iterations between theory and
experimentation to identify the parameters that link adjacent scales. This modular model
establishes algorithms for modeling over a wide range of scales and provides a framework
for the inclusion of other responses such as inﬂammation or therapeutic regimes.The goal
is to develop this lung model so that it can make predictions about bronchoconstriction
and identify the pathophysiologic mechanisms having the greatest impact on AHR and its
therapy.
Keywords: smooth muscle contraction, latch-bridge, calcium oscillations and waves, asthma, computational
modeling, parenchyma tethering
INTRODUCTION
Airway hyperresponsiveness (AHR) is deﬁned as an excessive
and inappropriate narrowing of the airways in response to bron-
choconstrictive challenge. While AHR and inﬂammation are hall-
marks of asthma and are primarily responsible for patient dyspnea,
we still have an incomplete understanding of how airway smooth
muscle (ASM) activation leads to airway narrowing and why
asthma exacerbates this response.
Nevertheless, it is clear that AHR involves a dynamic balance
between the active forces generated by ASM and the opposing
passive forces exerted by the airway and surrounding parenchy-
mal tissues. Importantly, these forces manifest at many length and
time scales; from molecular interactions within cells to changes
in airway morphology at the level of the whole lung. Further-
more, these forces are dynamic and, in particular, are rhythmi-
cally modulated by the act of breathing. For practical reasons,
traditional experimental approaches tend to focus on speciﬁc levels
of time and length scale and this has resulted in the accumula-
tion of numerous disparate facts about many of the individual
mechanisms pertaining to AHR. However, a clear view of how
these mechanisms interact to mediate AHR has remained elusive
because of the difﬁculty of integrating the many different time and
length scales involved.
It is our view that computational modeling provides a way
forward, therefore our primary goal is to construct a multi-level
computational model of the lung that embodies the key mecha-
nisms impinging on the phenomenon of airway responsiveness.
Such a model will not only contribute to a more complete under-
standing of the pathogenesis of AHR, but it will also provide a
virtual laboratory for in silico investigation of potential new ther-
apies for obstructive lung diseases and their modes of delivery.
This is particularly important in the current era of evidence-based
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medicine in which advances in medical practice are driven by the
outcomes of clinical trials. The expense and effort involved in such
trials are considerable and only a very limited number of questions
can be addressed. It is therefore crucial that these questions be
selected on the basis of their having the greatest likelihood of yield-
ing useful results. This can be greatly facilitated if the questions are
ﬁrst vetted on the basis of predictions made by a computational
model of the lung that integrates experimental data relevant to
AHR from all relevant length and time scales.
So far, our modeling and experimental studies have focused on
the basic mechanisms of ASM contraction in the healthy state. The
initial aim was to develop the basic model framework onto which
pathological conditions could be imposed. The obvious next step
will be to include, in the case of asthma, the complex process of
inﬂammation. Unfortunately, at the current time, we have inade-
quate information ormodels reﬂecting the action of inﬂammation
on ASM. Therefore, we have not attempted to extensively address
this complex aspect of asthma in this review.However, experimen-
tal work is proposed to examine ASM responses from asthmatic
tissues.
MULTI-SCALE COMPUTATIONAL MODELING
An interest in creating multi-scale models of biological systems
has developed rapidly in recent years along with the availability
of the required computing power. However, models of biological
systems should always be motivated by the need to address bio-
logical questions rather than a demonstration that a model can be
created. Furthermore, the purpose of a multi-scale model must be
more than just a representation of the biological system at different
scales of length or time. Ideally, the model must provide scientiﬁc
insight, particularly in terms of how changes in behavior at one
level of scale inﬂuence behavior at other scales within the system.
Biological systems are hierarchical; organs are composed of
tissues, tissues of cells, cells of organelles, and organelles of macro-
molecules, with each step exhibiting qualitatively different behav-
iors. Importantly, interactions between these scales often lead to
emergent phenomena that cannot be envisaged when considering
only a single scale. Thus, a key goal of multi-scale modeling is to
understand how integration of system components at one level
of scale produces emergent behavior at higher levels of scale. The
model should also provide the reverse function to elucidate how
high scale behavior can inﬂuence lower scale activity. Multi-scale
modeling requires the distillation of these scale-dependent behav-
ioral characteristics into their essential elements for inclusion into
the model rather than the inclusion of every detailed interaction.
This approach is more efﬁcient from a computational viewpoint
and facilitates the likelihood of gaining insight and understanding.
PRINCIPAL LENGTH AND TIME SCALES INVOLVED IN AHR
Because ASM is the source of contractile force in the airway, AHR
is a manifestation of its activity. This activity has consequences at
four major scales: that of the molecular, the cell, the tissue, and the
organ scale.
At the molecular scale
Airway smooth muscle cell (ASMC) contraction is produced by
the cyclic cross-bridge formation between myosin and actin that
generates force and movement; the kinetics of these cross-bridge
interactions primarily determines force-velocity output. However,
these cross-bridges can take a unique formcalled latch-bridges that
maintain the ASMC at a shortened length to exert prolonged con-
traction. For the model, characterization, and understanding of
these two cross-bridgemechanisms are required in order to predict
their force output and how molecular alterations of actin-myosin
interactions may be useful for the relaxation of ASMCs.
At the cellular scale
The contractile activity of the actin-myosin ﬁlaments is enzy-
matically regulated by the antagonistic activities of myosin light
chain (MLC) kinase (MLCK) and MLC phosphatase (MLCP). The
activity of MLCK is in turn regulated by complex spatiotemporal
patterns of Ca2+ changes within the ASMC, while MLCP is regu-
lated by a phosphorylation signaling cascade primarily involving
Rho Kinase. Of equal importance are the signaling pathways that
lead to ASMC relaxation; while this can simply involve the cessa-
tion of Ca2+ signals, the activation of relaxing signals mediated
via protein kinase A (PKA; via β2-adrenergic agonists) or protein
kinase G (PKG; via NO production) is frequently involved. The
contractile activity of the ASMC thus reﬂects a balance between
opposing signaling cascades. Consequently, characterization of
these regulatory mechanisms of ASMCs is required to make the
model responsive to external contractile stimuli.
At the tissue scale
Airway constriction is a dynamic event reﬂecting the opposing
inﬂuences of the active forces generated by ASMCs, which act to
narrow the airway, and the passive mechanical forces of the air-
way wall and the surrounding parenchyma, which resist airway
narrowing. The passive forces are due to numerous structures in
and around the airways including the alveolar walls that tether
the airway from the outside, the compressive stiffness of airway
wall components such as the epithelium and basementmembrane,
and the intrinsic stiffness of the ASMC itself. All of these fac-
tors, including the force-generating capacity of the ASMC, have
the potential to become markedly altered in diseases that involve
signiﬁcant degrees of airway remodeling, such as asthma. A par-
ticular challenge in modeling AHR at this level of scale is thus to
identify those mechanisms that have the most inﬂuence on airway
narrowing.
At the organ scale
The lung has a complex anatomy comprising of asymmetrically
branching airway and vascular trees embedded in viscoelastic
parenchymal tissue. In health, this structure brings air andblood in
close juxtaposition over the enormous surface area that is required
for adequate diffusive ﬂuxes of oxygen and carbon dioxide, with
regional variability in ventilation-perfusion matching having a
small inﬂuence on total lung gas exchange. In a lung suffering from
AHR, however, substantial heterogeneities of regional mechani-
cal function may arise that severely alter the ventilation-perfusion
ratios, compromising gas exchange.A computationalmodel that is
able to recapitulate this type of behavior, therefore, must incorpo-
rate accurate anatomical geometry together with local mechanical
properties of both airway and tissue. The respiratory tract is in
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constant motion as a result of breathing. Consequently, the spatial
distribution of local changes in airway constriction will deter-
mine the overall airway impedance, which in turn will inﬂuence
the distribution and ease of ventilation. To understand this com-
plex behavior, it is necessary to model breathing dynamics in
addition to the branching geometry,material properties, and inter-
dependence (through parenchymal tethering) of the airways and
parenchyma inwhich they are embedded. Thismodel incorporates
the foregoing scales and therebyprovides the ability to observe how
emergent properties alter ventilation.
APPROACHES TO MODELING
Predictive modeling
It is common for models to be purely constructive, i.e., con-
structed in great detail and validated by comparison to existing
experimental data. Because these models essentially provide a
quantitative explanation for what was already known, they are
constrained in their usefulness. By contrast, a model based on
physiological principles that can predict novel outcomes that are
not intuitively obvious, but which can be experimentally tested, is
extremely valuable for advancing an understanding of a system.
This modeling approach is successful because it inspires further
investigation and thereby provides additional evidence with which
to evaluate the predictions. This property of predictive models is
the key reason for constructing a multi-scale model of the air-
way, because it is only with such a model that the complicated
behavior of AHR can be evaluated. While experimental investiga-
tions are forced to accept limitations, predictive modeling is less
constrained.
Functional modeling
A major caveat of building a multi-scale model is that, at least
in the initial stages, it is undesirable to include all known com-
plexities. From a practical viewpoint, an all-inclusive model is not
feasible because such a model would require excessive computing.
Importantly, the model should be constructed on fundamental
principles of operation. Most researchers agree with this premise,
but can quickly lose conﬁdence in amodel if speciﬁc details central
to their work are not included. However, it is common that the sig-
niﬁcance of such details to the overall system is rarely known and
therefore must be initially omitted. With a basic working model,
additional complexity can be added, if validated by iterative testing
between model and experiment.
Our approach to building an airway lungmodel initially follows
the fundamental concept of force generation by myosin and actin
that is primarily controlled by cellular Ca2+ and converted into
airway narrowing by the mechanical properties of the lung as out-
lined across the four major scales. The auxiliary control processes
and tissue characteristics can then be applied to this framework. In
this review the important details of the physiological process will
be initially addressed, for each of the four major scales, followed by
the relevant modeling approaches to build the sub-models of each
scale. It must be emphasized that this is an on-going endeavor and
that the parameters currently included in the model only reﬂect
current progress. Theultimate aim for themodel is for it to become
apredictive tool that canbeused for clinical evaluation and insight.
This will require substantially more complexity, but the ﬁrst step is
the construction of a robust foundation and a ﬂexible open-source
framework for future development.
Our approach to multi-scale modeling
To construct a multi-scale model there are two major problems
that must be solved. Firstly, models for each level need to be
constructed, validated against existing data, and improved iter-
atively with additional experimental data. In general, this ﬁrst step
uses traditional modeling methods and is largely based on existing
approaches. Secondly,methods must be devised for coupling these
scales together into a single uniﬁedmodel. At this stage, newmath-
ematicalmethodsmayneed tobedeveloped.There areno standard
procedures for the construction of such multi-scale models; every
multi-scale model, particularly one that spans such a wide range
of spatial scales as ours, will likely depend on the invention of new
methods. In addition, the entire multi-scale model must be mod-
ular in order to avoid the rebuilding of the entire model with each
new iteration or error correction at each scale.
Linking the various spatial scales requires connecting partial
and ordinary differential equations, together with judicious use of
linearization and interpolation methods. Our approach has been
to retain, as far as possible, the richness of our cellular and sub-
cellular models (an alternative would have been to parameterize a
lumped-parameter model to represent their essential behaviors).
This means that we can explore the sensitivity of the large-scale
model behavior to perturbations at the smallest scales; for exam-
ple, in our multi-scale model it is possible to predict how changes
at the level of myosin and actin kinetics will affect ventilation or
heterogeneity at the level of the entire lung. Without a multi-scale
model, such predictions are simply not possible. One drawback is
that computations for a whole lung are demanding. We minimize
this problem by use of interpolation methods in the coupling of
the spatial scales, but each full model simulation may still take
many days of computer time.
THE MOLECULAR SCALE
CONTRACTILE MECHANISMS AND PROTEINS
The contraction of ASM cells appears to be mediated by a two-
step process; the ﬁrst or precursor step is proposed to be a
dynamic assembly of actin ﬁlaments into a cortical cytoskele-
ton that couples the cell membrane with more central and stable
actin ﬁlaments to enable effective force transmission. This is fol-
lowed by the traditional or familiar role of force generation by
cyclic myosin interactions with the pre-formed or stable actin
ﬁlaments.
The formation of the cortical cytoskeleton is reviewed by Gunst
and Zhang (2008) and is only brieﬂy summarized here. A key
observation is that agonist-induced tension development is largely
inhibited, in a manner independent of MLC phosphorylation, by
preventing actin polymerization (Adler et al., 1983; Mauss et al.,
1989; An et al., 2002; Shaw et al., 2003). This cytoskeletal assem-
bly involves an increase of ∼20% F-actin (and decrease of ∼30%
G-actin), occurs quickly (within ∼60 s) and involves the translo-
cation and interaction of numerous actin-binding proteins and
nucleation factors to the adhesion junctions that link the cytoskele-
ton to the extracellular matrix (Gunst and Zhang, 2008; Huang
et al., 2010; Zhang et al., 2010b). Gunst and Zhang (2008) propose
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that this dynamically polymerizing actin is required to transmit
and potentially amplify the forces generated by the more central
actomyosin interactions to the cell-surface.However, it is unclear if
this cytoskeletal formation is immediately reversed when the ASM
relaxes (e.g., upon agonist removal) or if an extended relaxed state
is required. At the current time, our modeling approach assumes
a ﬁxed anchorage of the actin-myosin ﬁlaments but the inclusion
of a cortical cytoskeletal sub-model would be a desirable future
direction.
The contractile or “functional” sarcomere
Airway smooth muscle cells generate force by the hydrolysis of
MgATP (magnesium ion-adenosine trisphosphate) which pro-
vides the energy to power a sliding ﬁlament mechanism mediated
by cyclic interactions between myosin ﬁlament heads and actin
ﬁlament binding sites (Adelstein and Sellers, 1996). The actin ﬁla-
ments are approximately orientated along the length of theASMCs
(Stephens and Kroeger, 1980). Traditionally, it was believed that
actin ﬁlaments were embedded in dense bodies that served as
anchor points at the cell membrane or within the cell (Bond and
Somlyo, 1982; Fay et al., 1983). However, more recent studies have
observed that dense bodies are actually tubular structures that run
parallel to the contractile ﬁlaments (Zhang et al., 2010a). Never-
theless, it is likely that actin ﬁlaments are anchored in some sort
of alpha-actinin based structure, similar to the z-lines of skeletal
muscle, so that contraction at the molecular level can be transmit-
ted to the cellular scale (Gunst and Tang, 2000; Gunst and Zhang,
2008).
The myosin ﬁlaments are interspersed between the actin ﬁla-
ments and typically appear thicker being composed of multiple
myosin dimers with the myosin heads projecting outward toward
the actin ﬁlaments (Trybus, 1996).Whereas the myosin heads have
a bi-polar orientation in striated muscles, in smooth muscle most
of the myosin ﬁlaments have a side-polar orientation (Xu et al.,
1996). The exact nature of the myosin ﬁlaments also varies with
the contractile state (Ip et al., 2007). From electron microscopy
observations, the thickest and longest myosin ﬁlaments appear to
occur in relaxedASMCswhereasmyosin ﬁlaments appear to redis-
tribute and are difﬁcult to observe in contractedASMCs (Chin and
Seow, personal communication). A possible explanation for this is
that unconnected myosin dimers may be able to mediate ﬁlament
sliding.
Regulation of myosin cross-bridge activity
The ability of myosin to perform force-generating cross-bridge
cycling is regulated by Ca2+/calmodulin-MLCK dependent phos-
phorylation of the regulatory MLCs (rMLC). Once phosphory-
lated, myosin can hydrolyze MgATP into MgADP and Pi and
associate with actin ﬁlaments to generate force. It is believed
that the faster kinetics of rapidly contracting phasic smooth mus-
cle (e.g., in intestines), as compared to slower contracting tonic
smooth muscle (e.g., in blood vessels), is caused by a faster reg-
ulatory and contractile system (Horiuti et al., 1989). However, it
is unclear whether ASMC exhibits a tonic (Horiuti et al., 1989)
or phasic (Malmqvist and Arner, 1991) phenotype. Furthermore,
ASMmay potentially change its behavior in disease (Souhrada and
Dickey, 1976; Davis et al., 1982).
Several accessory proteins, including tropomyosin, caldesmon,
calponin, and transgelin are all structurally associated with the
actin ﬁlaments (Morgan and Gangopadhyay, 2001) and are pro-
posed to play a role in contraction regulation. Tropomyosin
appears to have similar properties as in skeletal muscle and
facilitates cooperativity between cross-bridges (Morgan and Gan-
gopadhyay, 2001) as well as the action of caldesmon (Shirin-
sky et al., 1992). Caldesmon inhibits actomyosin ATPase activity
(Nagai et al., 1989) and decreases the actin sliding velocity (νmax)
in in vitro motility assays (Shirinsky et al., 1992; Horiuchi and
Chacko, 1995). The inhibitory action of caldesmon is reversed
by its phosphorylation that can be achieved by several agents
includingCa2+-calmodulin,CamKinase II (Ngai andWalsh,1984;
Shirinsky et al., 1992).
Similarly, calponin inhibits actomyosin ATPase activity
(Winder et al., 1998) and decreases νmax in in vitro motility assays
(Shirinsky et al., 1992). Contrary to the effect of calponin, this
decrease in νmax is more of an “all or none” mechanism. That
is, some of the ﬁlaments are completely stopped rather than dis-
playing a simple decrease in νmax (Shirinsky et al., 1992). This
inhibitory action of calponin is reversed by its phosphorylation
by PKC or Cam Kinase II, etc. (Winder and Walsh, 1990; Winder
et al., 1998).
Taken together, the above data suggest that activation (by
phosphorylation) of actin regulatory proteins may be necessary
for cross-bridge cycling and contraction (Winder et al., 1993;
Gerthoffer et al., 1996; Pohl et al., 1997). However other studies
reported the absence of phosphorylation in vivo (Gimona et al.,
1992; Adam et al., 1995).
Transgelin (SM22α), a ubiquitous protein found in smooth
muscle cells (Solway et al., 1995; Fu et al., 2000), is thought to
interact with, or bind to, actin (Gimona and Mital, 1998; Fu et al.,
2000) and potentiallymodulate actin cytoskeleton organization by
increasing F-actin bundling to enhance contractility (Han et al.,
2009). Studies on smoothmuscle fromSM22αknockoutmice have
demonstrated that SM22α is necessary for Ca2+ independent con-
tractionbut not forCa2+ dependent force generation (Je andSohn,
2007). Interestingly, SM22α appears to be signiﬁcantly increased
in asthmatic ASMCs, at least at the mRNA level (Leguillette et al.,
2009).
Enhanced contraction rates in AHR
There are two isoforms of smooth muscle myosin heavy chain
(SMMHC) that are generated by alternative mRNA splicing at
the amino-terminus (Eddinger and Murphy, 1988; Nagai et al.,
1989). These isoforms differ by the absence [(−)insert] or pres-
ence [(+)insert] of a seven amino acid sequence near the ATPase
site (Kelley et al., 1993; White et al., 1993). The importance of
this insert is that it doubles the actin-activated ATPase activity and
actin ﬁlament movement in in vitro motility assays (νmax; Kelley
et al., 1993; Rovner et al., 1997; Lauzon et al., 1998). Myosin puri-
ﬁed from multiple rat tissues shows a rank correlation between the
(+)insert protein expression and νmax (Leguillette et al., 2005).
Airway smooth muscle cells from asthmatics and animal mod-
els of asthma exhibit increased rates and extents of shortening
(Jiang et al., 1992; Bramley et al., 1994; Mitchell et al., 1994; Fan
et al., 1997; Wang et al., 1997). This increased shortening rate
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correlates with the over-expression of the fast SMMHC mRNA in
asthmatic human ASMCs (Leguillette et al., 2009). Increased rates
of ASM shortening have also been correlated with increased levels
of MLCK (Jiang et al., 1992, 1995; Ma et al., 2002), but a direct link
between rMLC phosphorylation and shortening velocity remains
controversial (Gerthoffer, 1987; Merkel et al., 1990; Mitchell et al.,
2001). Thus, the importance of increased activation or altered
expression of contractile proteins in AHR is unknown.
The latch-state
The latch-bridge, or latch-state, is a unique form of the myosin
cross-bridge and was originally deﬁned as a state of force mainte-
nance that occurswhen rMLC is deactivated by dephosphorylation
while the myosin head is still attached to actin (Dillon et al., 1981).
Despite the wide acceptance of this hypothesis, a veriﬁcation of
the occurrence of latch-bridges at the molecular level is lacking
in both animal and human tissues. This latch-bridge hypothe-
sis also assumes that myosin must be initially phosphorylated in
order to attach to actin (Hai and Murphy, 1988). However, tonic
force can develop with little or no rMLC phosphorylation sug-
gesting that latch-bridges can be formed by dephosphorylated or
unphosphorylated myosin (Sato et al., 1992). Indeed, evidence is
accumulating to suggest that unphosphorylated myosin can attach
to actin (Leguillette et al., 2008) andour preliminary data also indi-
cate that it can occur in the presence of actin regulatory proteins.
Furthermore, the (−)insert SMMHC is preferentially expressed in
tonic smooth muscle, where the latch-state is prevalent. This sug-
gests that the unphosphorylated isoform might play a role in force
maintenance (Leguillette et al., 2008).
In an alternative hypothesis for latch-bridge formation, the
rMLC remains phosphorylated but force regulation is modulated
by caldesmon and calponin (Hai and Kim, 2005). Because, in
asthma, there is a possibility that contractile protein expression
and function are altered by airway inﬂammation, latch-bridge
formation may contribute to the force maintenance observed in
AHR.
Dynamic relaxation of ASMCs
A striking feature of AHR in asthmatic subjects is an apparent
failure of the ASMCs to relax in response to deep inspiration.
The putative mechanisms for this clinically important effect (An
et al., 2007) include an alteration of the molecular mechanisms
of ASMC force production. Force generation in ASMCs normally
results from rapidly cycling cross-bridges but may also result from
slowly cycling latch-bridges. These latch-bridges have the potential
for force maintenance and thereby prevent relaxation of asthmatic
airways (Fredberg et al., 1997). Alternatively, sustained contrac-
tion may result from a reduced rate of myosin dephosphorylation;
a condition consistent with increased Ca2+-sensitivity mediated
by Rho activated Rho kinase (ROK; Somlyo and Somlyo, 2003).
EXPERIMENTAL APPROACHES
Multiple studies have addressed and compared the mechanical
properties of normal or asthmatic ASMCs, but none of these stud-
ies have performed a multi-level investigation of the component
proteins in a single animal species. Our approach is to charac-
terize how the basic properties of ASMC proteins (from mice,
rats, and humans) inﬂuence actin-myosin interactions in terms of
sliding velocity and force production. These studies will provide
the parameters necessary to build our model of the normal and
hyper-responsive lung.
Puriﬁcation of ASMC proteins
The functional analysis of individual myosin molecules from ani-
mal models has only recently been made possible by our devel-
opment of techniques to purify it from small tissue samples
(Sobieszek, 1994; Leguillette et al., 2005). The main challenge in
smooth muscle myosin puriﬁcation is to detach it from actin. This
is achieved by extracting myosin in folding conditions, decreasing
its access to actin (Sobieszek, 1994) followed by myosin ﬁlament
formation. Precipitation of myosin is then performed by ammo-
niumsulfate fractionation.Myosin fractions are thendissolved and
dialyzed against low-salt buffer topurify themyosinﬁlaments from
tropomyosin. The puriﬁed myosin is then thiophosphorylated,
a stable form of phosphorylation that allows mechanics studies
without the confounding effect of dephosphorylation. This puriﬁ-
cation procedure has made possible, for the ﬁrst time, the study of
ASM myosin from rat models of asthma (Leguillette et al., 2005).
In vitro motility assays
The in vitro motility assay (Figure 1) consists of observing the slid-
ing velocity of ﬂuorescently labeled actin ﬁlaments as they are pro-
pelled by myosin molecules randomly adhered to a nitrocellulose-
coated coverslip (Warshaw et al., 1990; Leguillette et al., 2008). The
role of the actin regulatory proteins can be addressed by adding
them individually or in combination to the assay. The sliding veloc-
ity (νmax) of single actin ﬁlaments is determined in presence of
MgATP and is calculated by dividing the path length traveled by
the elapsed time.
Force measurements with optical tweezers
The laser trap assay is used to measure unitary displacement and
force generated by myosin molecules. The assay uses laser light to
create potential energy wells which are capable of capturing and
manipulating beads in solution (Dupuis et al., 1997). By attaching
actin ﬁlaments to two such beads, a single ﬂuorescently labeled
actin ﬁlament can be brought into contact with myosin molecules
adhered to apedestal on a coverslip. Thedisplacement distance and
attachment time of a single myosin molecule can be estimated by
measuring the movement of one of the beads while myosin under-
goes its power-stroke. Alternatively, the force generated by a single
myosin molecule can be estimated by using a feedback system to
prevent beadmovement by generating an equal andopposite force.
The laser trap can also be used to measure the behavior of several
myosin molecules at a time (Leguillette et al., 2008; Figure 2A). In
this case, only one bead is required to bring an actin ﬁlament in
contact with multiple myosin molecules. Displacement and force
will again be estimated from the displacement of the bead and
normalized by the actin ﬁlament length or the estimated number
of myosin molecules interacting with the ﬁlament. To estimate the
force of binding of non-phosphorylated myosin to actin (myosin
molecules that donot generatemovement) the actin-attachedbead
is moved away from the pedestal at constant velocity (Figure 2B).
When thepulling force exertedby the laser trap exceeds the binding
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FIGURE 1 |The in vitro motility assay.The in vitro motility assay consists of
measuring the velocity (νmax) of actin ﬁlaments as they get propelled by
myosin molecules randomly adhered to a microscope coverslip (B). The
ﬂow-through chamber to setup and perform the assay is constructed from a
nitrocellulose-coated coverslip and a microscope slide separated by plastic
shims (A).
force of the non-phosphorylated myosin molecules to actin, the
trapped bead snaps back to its unloaded position (Figure 2C). The
product of the laser trap stiffness (Dupuis et al., 1997) and themax-
imum distance between the bead and the trap center (Figure 2B)
gives the binding force of the unphosphorylated myosin to actin.
This force is then normalized as above.
MODELING APPROACHES AT THE MOLECULAR SCALE
Our initial model of the smooth muscle cross-bridge cycle (Wang
et al., 2008) is based on a modiﬁed version of the Hai–Murphy
model (Hai and Murphy, 1988; Mijailovich et al., 2000; Hai and
Kim, 2005; Figure 3). Myosin is assumed to exist in one of four
states: the base state of myosin (M) that is neither phosphory-
lated nor attached to actin; a phosphorylated myosin that is not
attached to actin (Mp); a phosphorylated myosin that is attached
to actin (AMp); and a myosin that is attached to actin but not
phosphorylated (AM).
Myosin can only exert a force when it is attached to actin. The
transition from Mp to AMp, i.e., the attachment of phosphory-
lated myosin to actin, is believed to occur upon hydrolysis of ATP.
During the cross-bridge cycle, myosin cycles between the Mp and
AMp states, continually binding to and unbinding from actin, and
hence consuming ATP to generate force. By controlling the rate
of myosin phosphorylation, the ASMC can presumably control
the velocity of shortening and the amount of force generated. The
Ca2+-dependent mechanisms by which myosin phosphorylation
is regulated are discussed in Section “The Cellular Scale.”
In smooth muscle, myosin is believed to remain attached to
actin after dephosphorylation (Dillon et al., 1981). As mentioned
above, this state (AM) is called the latch-state. Because the rate of
transition from AM to M is typically slow, this allows the smooth
muscle to remain in a state where it can no longer relax or con-
tract quickly, but requires less ATP to maintain contraction. The
kinetics of the latch-state, as well as that of the cross-bridge cycle
are vital for understanding ASMC contraction and relaxation.
This model plays two major roles. Firstly, it is the force-
generating mechanism that, ultimately, results in airway narrow-
ing in the full multi-scale model. To accomplish this, the model
parameters are determined by comparison with data taken from
molecular scale experiments, as well as data collected from muscle
strips. Thus, we aim to ensure the model generates physiological
levels of force when incorporated into the multi-scale model. Sec-
ondly, the model can be used as a predictive tool to understand
the consequences of the possible binding of unphosphorylated
myosin.
In addition to modeling the cross-bridges with a version of the
Hai–Murphy model, our molecular scale model also includes a
hypothetical type of binding protein, which we call a cross-linker
(Donovan et al., 2010). Cross-linkers are included to give a bio-
physical basis for the plastic-like properties of unactivated smooth
muscle, such as ﬂuidization upon stretching. They are modeled
similarly to cross-bridges, except that the attachment functions
are symmetrical with respect to the distance variable. A cross-
bridge generates active force as a result of the attachment function
being asymmetrical, thus biasing the cross-bridge to bind in a posi-
tion that exerts active force. An identical binding mechanism, but
one with a symmetrical binding function, does not generate active
force,but exhibits similar dynamic behavior upon stretching. Since
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FIGURE 2 |The laser trap assay.To measure the force of binding to actin of
unphosphorylated myosin, a single beam laser trap assay is used as follows:
The laser trap is used to capture a polystyrene bead coated with
N -ethylmaleimide modiﬁed myosin. Such myosin can attach to actin but does
not cycle, so it is used to glue the ﬂuorescently labeled actin ﬁlament. The
actin is then brought in contact with the randomly adhered unphosphorylated
myosin on a pedestal on the coverslip (A). After allowing time for binding, the
pedestal is moved away from the laser trap at constant speed (B). Initially, the
bead remains offset from the trap center. When the pulling force exerted by
the trap exceeds the binding force of the unphosphorylated myosin molecules,
the bead springs back into the trap center, its unloaded position. (C)The
unbinding force is the product of the maximal distance between the bead and
the trap center (Δd ) by the trap stiffness. This force can be normalized by the
number of myosin molecules estimated to interact with the actin ﬁlament.
the cross-linker model is validated mostly by comparison to data
collected at the tissue scale, and has no known speciﬁc associated
proteins, it is discussed further in Section “The Tissue Scale.”
THE CELLULAR SCALE
PHYSIOLOGICAL SIGNALING MECHANISMS
Ca2+ oscillations and waves
A fundamental stimulus for ASMC contraction is an increase in
[Ca2+]i. This commonly occurs in ASMCs in response to ago-
nist activation of G-protein coupled receptors (GPCRs; Sanderson
et al., 2008; Figure 4). We have found that Ca2+ oscillations
are induced in mouse, rat, and human ASMCs by methacholine,
5HT, histamine, NO, endothelin, and LTD4 (Perez and Sander-
son, 2005; Perez-Zoghbi and Sanderson, 2007, 2010; Bai et al.,
2009; Ressmeyer et al., 2010). However, changes in membrane
potential (e.g., induced with external KCl) can also lead to Ca2+
changes (Perez-Zoghbi et al., 2009; Figure 4). The key function
of the increased [Ca2+]i is the activation, via calmodulin, of
MLCK to phosphorylate rMLC to initiate cross-bridge formation
(Figure 3) Consequently, the form and magnitude of the Ca2+
signals inﬂuence the extent of force generation.
Importantly, these changes in [Ca2+]i in ASMC from the small
airways of a variety of species in near in situ conditions occur as
sustained Ca2+ oscillations rather than static elevations of [Ca2+]i
while the agonist remains present (Figure 5; Sanderson et al., 2008;
Bai et al., 2009; Delmotte and Sanderson, 2010; Perez-Zoghbi and
Sanderson, 2010; Ressmeyer et al., 2010). Each Ca2+ oscillation is
often initiated at one end of the cell and propagates along the cell
as a Ca2+ wave. By correlating airway responses with the occur-
rence of agonist-induced Ca2+ oscillations, it has become clear
that increased airway contraction correlates with an increased
Ca2+ oscillation frequency (Figure 6; Sanderson et al., 2008;
Delmotte et al., 2010; Ressmeyer et al., 2010). Because it appears
that the frequency of the Ca2+ oscillations is important in force
regulation, this relationship is termed frequency-modulated (FM)
regulation (Berridge, 1997). However, the outcome of our mod-
eling indicates that this form of control involves more than just
the frequency aspect of the Ca2+ oscillation and probably relates
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FIGURE 3 | Schematic diagram of the cross-bridge model. Following Hai
and Murphy (1988) the myosin is assumed to exist in four forms;
unphosphorylated and unattached (M), phosphorylated and unattached
(Mp), phosphorylated and attached (AMp), attached and unphosphorylated
(AM). Cycling between the Mp and AMp states generates active force,
while the AM state can maintain tension but cannot generate force (and is
thus called the latch-state). Rates of phosphorylation are assumed to be
sigmoidal functions of Ca2+ concentration (c). The rates of attachment and
detachment are functions of the distance (x ) to the actin-binding site, and
thus the model is a system of partial differential equations of conservation
type.
to frequency-dependent changes in the form of the Ca2+ oscilla-
tions (Wang et al., 2010). A second interesting ﬁnding is that the
relationship between contraction and the frequency of the Ca2+
oscillations differs between species (Figure 6; Bai and Sanderson,
2009). In mouse, Ca2+ oscillations of about 20–30min−1 induced
a similar extent of airway contraction as 8–10Ca2+ oscillations per
minute in human airways (Ressmeyer et al., 2010). While some of
this difference may be attributable to the form of the Ca2+ oscilla-
tion at different rates, it is likely that a second mechanism termed
“Ca2+ sensitivity” is responsible (see later; Bai and Sanderson,
2009).
Mechanisms of agonist-induced Ca2+ signaling
Agonist-induced Ca2+ oscillations in ASMCs primarily rely
on Ca2+ release from the sarcoplasmic/endoplasmic reticulum
(S/ER). In general, agonist stimulation of GPCRs results in the
production of inositol trisphosphate (IP3). This, in turn, binds
to and releases Ca2+ from the S/ER via IP3 receptors (IP3Rs).
The sensitization of all the IP3Rs of an ASMC with IP3 primes
the ASMC to display Ca2+ oscillations and waves. A Ca2+ tran-
sient occurring at one group or cluster of IP3Rs leads to, by the
diffusion of Ca2+ through the cytosol, the stimulation of other
nearby IP3Rs to release Ca2+, a process called Ca2+-induced Ca2+
release (CICR;Berridge et al., 2003;Berridge,2009). The sequential
repeat of this activity propagates aCa2+ wave. Therefore, it appears
that Ca2+ wave properties are a consequence of Ca2+ diffusion
rates and IP3R distribution and sensitivity. The S/ER Ca2+ ATPase
(SERCA) pumps sequester much of the cytosolic Ca2+ back into
the S/ER to allow the process to recycle. Although a direct role for
Ca2+ inﬂux is not required for Ca2+ oscillations, the long-term
maintenance of Ca2+ oscillations does rely on the Ca2+ content of
the SR (Perez and Sanderson, 2005). Most likely, Ca2+ enters the
cell via a store-operated channel (SOC) inﬂux mediated by mem-
brane channels, Orai1, activated by STIM1, a Ca2+ sensor within
the S/ER (Parekh and Putney, 2005; Putney and Bird, 2008). How-
ever, when the S/ER Ca2+ content is low, Ca2+ may also enter via
receptor-operated channels, TRP channels, or the reversal of the
Na+-Ca2+ exchanger (Rahman et al., 2012).
Ca2+ oscillations have also been proposed to be mediated by
CICR via the ryanodine receptor (RyR) of the S/ER (Dai et al.,
2007). These may result by a direct inﬂux action of Ca2+ or fol-
lowing sensitization of the RyR by cADP-ribose (cADPR; Prakash
et al., 1998; Jude et al., 2008). However, in all our experiments
with normal lung slices, on-going Ca2+ oscillations or waves are
not inhibited in anyway by ryanodine (Bai et al., 2009), an antag-
onist of the RyR or antagonists of cADP-ribose. While other RyR
antagonists such as tetracaine do inhibit Ca2+ oscillations (Dai
et al., 2007), these appear to result from their non-speciﬁc anes-
thetic effects that decrease IP3 production or Ca2+ sensitivity (Bai
et al., 2009).
Ca2+ signaling associated changes in membrane potential
Membrane depolarization has commonly been associated with
smooth muscle contraction; and is believed to be mediated by
the opening of voltage-dependent Ca2+ channels and the inﬂux
of Ca2+ perhaps followed by CICR via the RyR (Janssen, 2002).
However,ASMCs in lung slices donot appear to follow this scheme.
In response to membrane depolarization, induced by external KCl,
ASMCsdisplayCa2+ oscillationswith a very slow rate (1–2min−1)
as compared to agonist-induced Ca2+ oscillations (Figure 5; Perez
and Sanderson, 2005; Bai et al., 2009; Ressmeyer et al., 2010).
Importantly, these Ca2+ oscillations have a signiﬁcantly differ-
ent appearance and occur as large prolonged increases in [Ca2+]i
that are preceded by numerous elemental Ca2+ responses. In con-
trast to agonist-induced oscillations, KCl-induced oscillations are
inhibited by ryanodine (Figure 5) and the removal of extracellular
Ca2+ (Perez and Sanderson, 2005; Bai et al., 2009). The implica-
tion is that KCl-induced oscillations are mediated by a slow Ca2+
inﬂux that overﬁlls the S/ER to sensitize the RyR to CICR.
It seems clear from these studies that both IP3Rs and RyR are
present in ASMCs, but they appear to function independently of
each other during normal Ca2+ signaling. However, since both
receptors rely on the same Ca2+ resource, they are unavoidably
linked by the Ca2+content of the S/ER. Indeed, slow Ca2+ oscilla-
tionsmediated by the RyR can be replaced by fast Ca2+ oscillations
via the IP3R. An explanation for this conversion is that the partial
emptying of the S/ER Ca2+ inactivates the RyR (Wang et al., 2010)
and this also explains why the RyR does participate in CICR Ca2+
signaling during IP3-dependent Ca2+ oscillations.
Ca2+ sensitivity
A complementary mechanism enhancing ASMC that works in
parallel to the activation of MLCK by Ca2+ is the inactivation
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FIGURE 4 | Airways in human lung slices. (A) A human small airway in
Hanks’ balanced salt solution (HBSS). (B) In response to 1μM MCH, the
airway has contracted. (C)The change in airway cross section area (as a % of
the initial area) in response to a variety of contractile stimuli. Agonists
Histamine, Methacholine and leukotriene D4 and membrane depolarization
with KCl induce airway contraction.
of the antagonistic enzyme, MLCP that dephosphorylates rMLC
to mediate ASMC relaxation (Schaafsma et al., 2008; Chiba et al.,
2010; Mbikou et al., 2011). The inhibition of MLCP is commonly
achieved by an increased activity of Rho kinase (ROK; by Rho A)
in response to the same agonist stimulation that induced increases
in Ca2+. Similar changes can be induced by PKC in response to
activation by diacylglycerol. Phosphorylation of the regulatory or
accessory proteins of MLCPbyROKor PKCprevent its association
with rMLC; decreased MLCP activity allows the phosphorylation
state of rMLC to persist (Somlyo and Somlyo, 2003; Sanderson
et al., 2008).
ASMC relaxation by β2-adrenergic receptor agonists
A major objective of therapies for AHR is the relaxation of con-
tractedASMCs and the prominent pharmaceuticals in this strategy
are β2-adrenergic receptor agonists. Although widely used, the
mechanism of action of these compounds is not fully understood
at the cellular level; a common belief is that increases in cAMP
lead to Ca2+ decreases and thereby relaxation.
Because it will be important to include β2-adrenergic recep-
tor signaling in our lung model, we have initially explored this
signaling pathway with lung slices (see below). An important
ﬁnding was that both short-acting (albuterol) and long-acting
(formoterol) β2-adrenergic receptor agonists slowed the Ca2+
oscillations induced by methacholine or histamine in mouse or
human airways (Delmotte et al., 2010). This appeared to be
achieved by a reduced activation-sensitivity to IP3 and increased
inhibition-sensitivity to Ca2+ of the IP3R (Bai and Sanderson,
2006a). The production of IP3 may have also been reduced in the
case of high formoterol concentrations (Delmotte and Sanderson,
2010). These conclusions appear to differ from earlier studies that
proposed that increased cAMPreduced internalCa2+ by activating
Ca2+-dependent K+ channels that mediate membrane hyperpo-
larization to reduce Ca2+ inﬂux (Kume et al., 1994). Although
the earlier studies implied that this was a direct mechanism to
reduce [Ca2+]i, it is not totally incompatible with decreased Ca2+
oscillation frequency if the Ca2+ inﬂux is directed to reﬁlling the
supportive Ca2+ store. This hypothesis has similar implications
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FIGURE 5 | Ca2+ oscillations in ASMCs in lung slices. (A–C)The
contractile agonists methacholine and histamine induce Ca2+ Oscillations in
mouse, rat, and human ASMCs in lung slices. The frequency of the Ca2+
oscillations varies between species. (D) KCl also induces Ca2+ oscillations
in human ASMCs in lung slices. Theses Ca2+ oscillations are slow and are
inhibited by RyR.
for the idea that spontaneous Ca2+ sparks, (mediated by RyRs)
that also activate Ca2+-dependent K+ channels and observed
in isolated ASMCs (Zhuge et al., 2010), serve as a relaxation
mechanism.
In addition to Ca2+ reduction, β2-adrenergic receptor ago-
nists also reduce the Ca2+ sensitivity of ASMCs. Importantly, this
effect is very potent with formoterol (Delmotte and Sanderson,
2010; Delmotte et al., 2010). At a low concentration (5 nM) that
is insufﬁcient to alter the Ca2+ oscillation frequency, formoterol
induces a substantial relaxation of the ASM. A change in ASMC
Ca2+ sensitivity may also explain some of the effects of mem-
brane hyperpolarization; with the Ca2+ clamped in a lung slice,
FIGURE 6 |The relationship between Ca2+ oscillation frequency of
ASMCs and the extent of airway contraction.The gradient of the
relationship is different for each species.
we have found that KCl (depolarization) also increased contrac-
tion. KCl can activate Rho kinase (Janssen et al., 2004) and this
suggests that hyperpolarization will decrease Ca2+ sensitivity to
help relax ASMCs. These mechanisms emphasize that Ca2+ sen-
sitivity is an equally relevant signaling mechanism that must be
considered when addressing the cause and relief of AHR (Chiba
et al., 2010).
EXPERIMENTAL APPROACHES
A major advance that has facilitated our investigation of the cel-
lular regulation of airway contraction is our ability to examine
changes in ASMC physiology while simultaneously measuring air-
way contraction. These correlations are made possible by a unique
lung slice preparation that has been used with mouse, rat, guinea
pig, horse, monkey (Sanderson, 2011), and most importantly,
human airways (Ressmeyer et al., 2010; Figure 4).
Brieﬂy, isolated lungs are re-inﬂated via the trachea to a nor-
mal size with a solution of warm agarose (∼2%). After cooling
and gelling of the agarose, the lungs are sufﬁciently stiff to be
cut into serial slices,∼200μm thick (Perez and Sanderson, 2005).
Only lung slices containing airway cross sections that lack agarose
within the lumen and have an intact epithelium and ciliary activity
are selected for study. Lung slices are robust, being viable for 3 days
and highly compatible with experimental imaging. By loading the
cells of the lung slice with Ca2+ reporter dyes, changes in [Ca2+]i
in ASMCs can be observed with scanning laser microscopy during
contraction.
The lung slices can also be used to investigate the mechanism of
“Ca2+ sensitivity.” This requires that the [Ca2+]i of the ASMCs is
“clamped” to a constant level. This is achieved by irreversibly emp-
tying the S/ER of Ca2+ by treatment with caffeine and ryanodine
to invoke continuous Ca2+ inﬂux via SOCs (Bai and Sanderson,
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FIGURE 7 | Schematic diagram of the Ca2+ model. Calcium can enter the
cytosol through IP3 receptors (IPR), ryanodine receptors (RyR), or generic
voltage-gated channels and leaks. Ca2+ is removed from the cytoplasm by
ATPase pumps on the membrane of the SR and on the plasma cell
membrane. IPR are activated by IP3, which is produced as an end-product
of agonist stimulation of cell-surface receptors. Calcium in the cytosol can
diffuse, and is heavily buffered. The buffers are not shown explicitly as they
are incorporated via an effective diffusion coefﬁcient and effective reaction
rates.
2006b; Cahalan, 2009). Increased force production under these
conditions implies that an alternative method besides Ca2+ is
acting.
MODELING APPROACHES
Ca2+ oscillations
The model of Ca2+ oscillations is based on the dynamics of Ca2+
leaving or entering the cytosol (Figure 7). Ca2+ can enter the
cytosol from outside the cell (Jin) or from the S/ER (JSR). Con-
versely, Ca2+ can be removed from the cytoplasm by Ca2+ATPase
pumps in the SR (Jserca) and the plasma membrane (Jpm). This
model construction is well developed (Falcke, 2004) and has been
used extensively to further develop our model and test predictions
(Sneyd et al., 2004, 2006).
Although the overall structure is simple, each of the individual
ﬂuxes can be modeled in a complex way; JSR includes Ca2+ ﬂux
through IP3 receptors (JIPR) as well as ryanodine receptors (JRyR).
The JIPR ﬂux also requires that we incorporate sensitivity to IP3
binding and Ca2+ feedback. In the initial version of the model,
this was achieved by using a model of the IP3R developed by De
Young and Keizer (1992), although more recent work uses more
modern IP3R models (Gin et al., 2009a,b,c; Siekmann et al., 2011).
The RyR is modeled using the model of Keizer and Levine (1996).
Jin incorporates Ca2+ ﬂuxes through voltage-gated Ca2+ chan-
nels and this is regulated by the membrane potential. Ca2+ inﬂux
via a capacitative Ca2+ entry mechanism or arachidonic-acid-
regulated channels is incorporated in the current model of mouse
ASMCs,but only in a simplistic way.More detailedmodels of Ca2+
inﬂux in human ASMCs are being developed by an associated
group (Croisier and Brook, unpublished).
Ca2+ buffering is modeled by incorporating a fast buffering
approximation. Nuclear and mitochondrial Ca2+ ﬂuxes, although
present, have a secondary effect and are modeled as immobile
buffers. The modulation of IP3 production and degradation is not
an important part of the mechanism underlying Ca2+ oscillations
in ASMC (Sneyd et al., 2006) so these pathways are not included.
Our current model of Ca2+ dynamics does not attempt to
include a wide variety of membrane ion channels that have been
found in ASM, primarily because there are few data directly link-
ing the activity of such channels to agonist-induced Ca2+ changes
in ASM in situ. Although a correlation of ASM contraction and
channel activity has been often observed, this is inadequate for
Ca2+ modeling since the underlying Ca2+ changes cannot be
assumed. The induction of slow Ca2+ oscillations by KCl is a good
example of an unexpected form of Ca2+ signaling in response
to a stimulus that is commonly expected to induce a sustained
Ca2+ elevation in response to the opening of voltage-dependent
Ca2+ channels. Ion channel activity may also affect Ca2+ sensi-
tivity. From our experience, we emphasize that it is essential to
collect information on contraction, Ca2+ changes and Ca2+ sen-
sitivity, before mechanisms and conclusions can be made with
models.
The full model provides a good ﬁt to Ca2+ oscillations induced
by stimulation with MCh (Figures 8A,B) and importantly has
made some interesting predictions (Wang et al., 2010). Although
experiments and model indicate that the RyR is not a key feature
of on-going Ca2+ oscillations, the model surprisingly predicts that
the ﬁrst Ca2+ transient is dominated by RyR activity (Figure 8).
This possibility was not original envisaged and resulted in experi-
mental design that only added ryanodine to on-goingCa2+ oscilla-
tions. However, an initial role for RyR can be experimentally tested
by having ryanodine present before the stimulation of Ca2+ oscil-
lations with agonist. A second model prediction is that the S/ER
Ca2+ content rapidly fallswith eachCa2+ oscillation to reach anew
but lower equilibrium. This lower S/ER Ca2+concentration pre-
dicts that the RyR will be insensitive to CICR and explains why the
RyR cannot contribute to on-goingCa2+ oscillations. Importantly,
themodel also reproduces the experimental response of slowCa2+
oscillations upon depolarization with KCl (Figures 8B,C). The
prediction of this aspect of the model is that the SR becomes over-
ﬁlled with Ca2+ to sensitize the RyR to CICR. The model further
predicts that agonist-induced oscillations would empty the SR so
that the KCl-induced Ca2+ oscillations operating through the RyR
would become inoperative as a result of reduced SR Ca2+. This
prediction was upheld in the experimental examination of cytoso-
lic Ca2+ oscillations; measurement of SR Ca2+ is still required
(Figure 8E).
Ca2+ waves
An important aspect of the Ca2+ signaling occurring within the
ASMCs is their spatial organization; each Ca2+ oscillation propa-
gates as a Ca2+ wave. This serves to distribute the stimulus equally
across the cell but it also determines the duration of the sig-
nal at points within the cell. To model this spatial behavior, it
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FIGURE 8 | A comparison of experimental and model Ca2+
oscillations induced by agonist (A,B) and KCl (C,D). Agonist-induced
Ca2+ oscillations are fast compared to KCl-induced Ca2+ oscillations. (E)
Experimentally, we observe that slow Ca2+ oscillations induced by KCl
are converted into fast Ca2+ oscillations by the addition of agonist in the
presence of KCl.
is necessary to incorporate a spatial distribution for the release
channels and to model the diffusion of Ca2+. The Ca2+ oscilla-
tions can then be visualized as propagating waves (for both agonist
and KCl stimulation) that reﬂect the experimental data (Wang
et al., 2010). However, the model predicts that both the IP3Rs and
RyRs need to be asymmetrically distributed; there appears to be
a requirement for receptor density to be greater toward one end
of the cell in order to reproduce the propensity for Ca2+ waves to
initiate at one end of the cell, as well as show intermittent wave
failure followed by a reversal of the wave propagation direction.
It is not clear why this organization is required, or if it occurs
biologically, but we intend to test this prediction by examining
receptor distribution.
Coupling Ca2+ signal to force production
To incorporate the cellular signaling into the larger lung model, it
is necessary to couple our Ca2+ dynamics model to our model for
force generation. We discussed the cross-bridge model in Section
“The Molecular Scale.” The coupling of Ca2+ to force generation
requires the activation of MLCK by Ca2+/calmodulin and we use
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a Hill function to mimic cooperative binding of four Ca2+ ions to
calmodulin.
Force generation also requires the consideration of myosin
dephosphorylation by MLCP. This is inﬂuenced by both agonist
and KCl. An additional complication is that in mouse but not
human ASMCs, MLCP appears to be activated (on a slower time
base relative to MLCK) by Ca2+ (Bai and Sanderson, 2006b, 2009;
Ressmeyer et al., 2010). To model fast Ca2+ activation of MLCK
followed by slower Ca2+ activation of MLCP, we introduced an
additional differential equation for Q, the fraction of activated
MLCP (Wang et al., 2008). The rate constants were determined by
ﬁtting to the airway response to a step increase in Ca2+ (Figure 3).
With this mouse model, that translates Ca2+ oscillations into
force production, we were able to explore the hypothesis of FM
regulation to identify the key features of the Ca2+ oscillations that
are the most signiﬁcant in force generation. Interestingly, whole-
cell Ca2+ oscillations (a simultaneous uniform increase in Ca2+
throughout thewhole-cell) induced greater force thanpropagating
Ca2+ oscillations (i.e., Ca2+ waves), even through the frequency
and mean Ca2+ concentration of the two processes were similar
(Wang et al., 2010). It is important to point out that in this mouse
model, a constant increase in [Ca2+]i induced less force than either
type of Ca2+ oscillation. This is believed to result, in part, from
the slow activation of MLCP that can decrease force. Therefore,
what appears to be important for force production is the shape or
duration of the Ca2+ oscillation. If the Ca2+ oscillation becomes
more like that of a constant increase in [Ca2+]i, (i.e., it broadens)
by becoming lower inmagnitude but longer in duration in the case
of a whole-cell Ca2+ oscillation or spatially broader in the case of
the Ca2+ wave, it will induce less force even though the mean Ca2+
remains little changed. This relationship between oscillatory Ca2+
changes and force may be different in human ASM cells, in view
of the fact that Ca2+ has less effect on Ca2+ sensitivity of human
ASM cells.
By examining the proportion of cross-bridges in the latch-state,
the model is used to determine the importance of the latch-state in
controlling the speed of relaxation. Initial results from the model
indicate that the gradualmovement of cross-bridges into the latch-
state causes a gradual decline in the speed of contraction, with a
power-lawdecayproﬁle (seeTheTissue Scale). Thesemodel results
agree qualitatively with experimental data. However, understand-
ing of the relationship between the latch-state, muscle stiffness,
and the speed of contraction remains incomplete.
Stochastic modeling of Ca2+ oscillations and waves
The currentCa2+ signalingmodels are deterministic.However, the
behavior of channels such as the IP3R, are for the most part, essen-
tially stochastic. Stochastic behavior is observable in long-duration
recordings of low frequency Ca2+ oscillations, which have an
increased variance in the inter-spike interval. Even at higher IP3
concentrations, i.e., at higher oscillation frequencies, there is clear
stochastic variation in the oscillation period. Consequently, a
major goal will be to convert our models to include stochastic
behavior, in order to see how important stochastic effects are in
force generation.
Our initial stochasticmodels have incorporated themost recent
data on the dynamical behavior of IP3R, collected from single
channels in the nuclear membrane (Betzenhauser et al., 2008). By
ﬁtting new Markov models to these single channel data, the next
generation of IP3R models has more accurately determined the
time scales of Ca2+ and IP3 control of IP3R open probability (Gin
et al., 2009a,b; Siekmann et al., 2011). Initial simulations using a
more accurate IP3R model suggest that a stochastic IP3R-based
model is unable to generate long-period oscillations. How such
long-period oscillations occur remains an open question.
Once stochastic effects are incorporated in the model, and
their effects on force generation determined, the challenge will
be to develop formulations of the stochastic model that allow for
coupling to the next higher spatial scale. There is no standard
methodology for such coupling, and new methods will have to be
developed.
THE TISSUE SCALE
The aim of the tissue scale model is to reproduce the active and
passivemechanical properties of ASMCs and the viscoelastic prop-
erties of the surrounding tissue against which the ASMC shortens.
However, ASMCs are complicated by the fact that their mechan-
ical properties are malleable depending on the physiological
circumstances.
ASMC AND TISSUE MECHANICAL PROPERTIES
Inherent ASMC properties
Airway smooth muscle cells exhibit a hyperbolic force-velocity
relationship (Hanks and Stephens, 1981) and a characteristic ten-
sion transient in response to step length changes (Fredberg et al.,
1997; Bates et al., 2009). However, this force-length relationship is
not ﬁxed; when stimulated repeatedly, at a given length, ASMCs
adapt in order to maintain their current length at the peak of the
force-length relationship (Bullimore et al., 2011). This provides
the ASMCs with the ability to generate maximal force even after
shortening; a response that, if unregulated, would enhance AHR.
In addition, and as mentioned earlier, ASMCs are able to form
latch-bridges. Such latch-bridges maintain force for long periods
with low energy consumption and a decreased ASMC shortening
velocity (Dillon et al., 1981; Fredberg et al., 1997). Thus, by enter-
ing the latch-state the mechanical properties of ASMCs markedly
change to a stiffened state. ASMCs also exhibit force adaptation;
total force gradually increases when ASM is stimulated repeatedly
in the presence of baseline tone (Gunst and Wu, 2001; Gunst et al.,
2003).
Parenchyma tissue properties
The dynamic environment of the in vivo airway is determined to
a substantial extent by the forces imparted by parenchymal teth-
ering. Parenchymal attachments to the outside of the airway wall
are responsible for conveying transpulmonary pressure from the
pleural surface to the airway wall, and thus impart an outwardly
directed force that opposes airway narrowing. Consequently,when
the airways are challenged with a smooth muscle agonist, their
contractile response is exquisitely sensitive to transpulmonary
pressure.
The mechanical properties of the parenchyma can be described
to a ﬁrst approximation in terms of a linear single-valued stress-
strain function such that transpulmonary pressure depends lin-
early on lung volume. This description accounts for the majority
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of the mechanical behavior that inﬂuences airways responsiveness
over the range of volumes encountered during normal breathing.
However, the stress-strain behavior of lung tissue exhibits signiﬁ-
cant strain stiffening beyond this volume range due to a variety of
mechanisms; a key mechanism being the progressive recruitment
of collagen ﬁbers that become straight and bear the load as volume
increases (Maksym and Bates, 1997; Maksym et al., 1998). Lung
tissue is also highly viscoelastic (Bates et al., 1994), so the outward
force it exerts on a tethered airway depends on volume history in
addition to the current volume itself.
EXPERIMENTAL METHODS
ASM strips
We have made substantial progress toward understanding the
mechanical behavior of activated and non-activated ASM by char-
acterizing the dynamic force-length behavior of strips of rat tra-
chealis muscle (Bates et al., 2009; Bullimore et al., 2011). We
measured the slowing of contraction velocity during activation
(a characteristic of the latch-state) and examined if the isotonic
releases inﬂuence the degree of velocity slowing. This was done by
comparing shortening velocity after 15min of isometric activation
with the shortening velocity of the same ASM strip when velocity
wasmeasured once permin for 15min.Velocity at 15minwas very
similar under the two conditions. We also studied velocity slowing
over time in ASM from rat and sheep trachea and found that the
time course of velocity slowing was similar in both preparations
and could be described by a power-law.
Stretching lung slices
To explore if airway stretching associated with breathing relaxes
airway ASM, lung slices can be stretched and changes in airway
size recorded. To ensure tethering is active, the lung slice periph-
ery must be stabilized and this can be achieved by attaching the
lung slice edge to a silicon sheet with glue. By applying oscillat-
ing stretches to the preparation the airway appears to simulate
the cyclic expansion during breathing. Preliminary data indicate
that human airways contracted with MCh respond to rhythmic
stretch by relaxing (Figure 9). When stretching ceased, the air-
way re-contracted. These results are consistent with the idea that
stretching is a protective mechanism against agonist-induced con-
traction, which was inspired by studies in isolated strips of ASM
(Fredberg et al., 1997; Wang et al., 2000) leading to the hypothesis
that ﬂuidization of the ASM causes its contractile state to be deter-
mined dynamically (Krishnan et al., 2008). On the other hand,
evidence of this effect in vivo is scant, being limited to volume
changes that are very large (Bates et al., 2007). Recent studies of
the contractile response of isolated airways subjected to trans-
mural pressure changes have also failed to show that pressure
oscillations reduce airway contractility (LaPrad et al., 2010; Noble
et al., 2011). Our working hypothesis is that the protective mech-
anism we observe in our explant preparation derives from the
dynamic properties of the ASM cross-linkers and cross-bridges,
which exhibit ﬂuidization when stretched. Nevertheless, it will be
interesting to see whether these effects manifest in a measurable
way at the level of thewhole organwhen incorporated into a global
model of lung responsiveness.
MODELING APPROACHES
Empirical models of ASM contraction dynamics
To model the dynamic force-length behavior of an ASM strip,
we have used two complementary approaches. One uses tradi-
tional viscoelastic theory (Bates et al., 2009) based on spring-and-
dashpot models and has the advantage that it is based on ordinary
differential equations and is therefore relatively straightforward to
simulate. Here, we assume that the contractile machinery in the
ASMC is presented as a force generator that acts in concert with
non-linear passive elements representing the connective tissues
that are mechanically arranged both in series and parallel with
the force generator. This model mimics the key features of the
oscillatory force-length behavior of ASM strips both when they
are passive and when the ASMCs are activated by an applied stim-
ulus (Figure 10). Of particular note, in order to reproduce the
rapid transient decrease in peak oscillatory force observed upon
the initiation of activation (Figure 10), it is necessary to have the
FIGURE 9 | Effect of stretch on airway contraction. A human airway
contracted with MCh and exposed to sequential uni-axial stretching to mimic
breathing (details of the effect of each stretch is shown in the insert box)
responded with an increase in the baseline of airway size (relaxed). When
stretching was terminated, the airway began to slowly re-contract in response
to the continual presence of MCH.
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FIGURE 10 | Force-time traces obtained in a strip of rat trachealis muscle.
The gray curves show data obtained with 2Hz length oscillations having
amplitudes of ±1, ±2, and ±4% baseline length as indicated. Isometric
force-time curves are shown in black (solid lines obtained prior to collecting
oscillation data, dashed lines obtained afterward). The black curves in the
right-hand panels show corresponding force-time plots simulated by a
lumped-parameter model of the ASM strip that includes an empirical
mechanism accounting for cross-bridge attachment and detachment kinetics.
force-generating capacity of the ASMCs be reduced in propor-
tion to the rate of change of ASM strip length. This mechanism
is still empirical, but is motivated by the notion that cross-bridge
attachment is impaired by relative movement of actin and myosin
ﬁlaments (Fredberg et al., 1999).
We have incorporated a simpliﬁed version of the above model
into a model of the contraction of ASM around an airway embed-
ded in the lung parenchyma in order to mimic the marked depen-
dence of airway responsiveness on transpulmonary pressure.Here,
it is necessary to take into account not only transpulmonary pres-
sure itself, but also the increased translumenal pressure across the
airway wall that arises from local distortion of the parenchyma
caused by airway narrowing. The latter can be usefully approx-
imated by a relationship derived by Lai-Fook (1979). Using this
relationship, together with the classic hyperbolic description of
the force-velocity relationship for ASM, the dynamic response of
the airways to intravenous methacholine over a range of inﬂa-
tion pressures can be accurately reproduced by a model consisting
of a single airway embedded within linearly elastic parenchyma
(Bates and Lauzon, 2007; Cojocaru et al., 2008). Importantly, the
adequacy of the model ﬁt (Figure 11) relies on the inclusion of
a ﬁnite stiffness to the airway wall, which provides a signiﬁcant
load opposing smoothmuscle shortening in addition to that of the
parenchyma itself. This approach to balancing the force of smooth
muscle contraction against the opposing mechanical loads can be
taken with respect to the individual airways in a model of the lung
that includes the branching structure of the airway tree, thereby
allowing regional differences in responsiveness to be taken into
account (Politi et al., 2010).
Mechanistic models of ASM force-length dynamics
The second approach we have used to model the dynamic force-
length behavior of theASM strip takes the underlying cross-bridge
mechanism speciﬁcally into account (Wang et al., 2008; Dono-
van et al., 2010). This approach has the advantage of a speciﬁc
biophysical basis, but it is based on partial differential equations
and is therefore more difﬁcult to implement than the spring-and-
dashpot model described above. Again, the dynamic mechanical
properties of ASM are obtained experimentally from its transient
force-length behavior during cyclic stretching, with peak force
and stiffness being initially high but rapidly falling to become
at or below isometric values. While some of this behavior can be
predicted using an adaptation of Huxley’s cross-bridge model of
skeletal muscle (Mijailovich et al., 2000) we have found that the
non-linear viscoelastic properties of ASM tissuemust also be taken
into account (Bates and Lauzon, 2005). However, this still does not
account for all the dynamic force-length behavior of ASM. In par-
ticular, when activated ASM is stretched to mimic deep inhalation,
there is a protracted decrease in its subsequent ability to generate
force that is not predicted by models based solely on cross-bridges.
We have proposed that this loss of ASM force generation results
from thedisruptionof the contractile apparatus (Bates et al., 2009),
the actin cytoskeleton, or other proteins comprising ASM and its
connections to the airway.
Models of passive parenchymal tissue
The modeling of soft tissue mechanics using empirical constructs
such as assemblies of springs and dashpots is well-established
(Fung,1981). Suchmodels donot,however, embody anyparticular
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FIGURE 11 | Airway resistance measured in mice (open circles:
mean±SEM) following an intravenous injection of
methacholine at time 0, when the lung inflation pressure was
set to the three different values indicated at the right of the
figure.The solid line shows the ﬁt provided by a computational
model of an elastic airway embedded in parenchyma that contracts
according to a hyperbolic force-velocity relationship. Adapted from
Cojocaru et al. (2008).
underlying biophysical mechanisms for complex tissue rheology;
indeed, this remains an active research ﬁeld that has much atten-
tion from both biological and physical scientists (Suki and Bates,
2011). Recently,wehave proposed anovelmechanism for the gene-
sis of the rheological behavior that has been observed in lung tissue
(Bates et al., 1994). This mechanism is based around the notion
that stress is released within stressed tissue through a sequence of
micro yield events that occur throughout the tissue (Bates, 2007),
as opposed to the smooth relative sliding of multiple components
as is implied by spring-and-dashpot models. The appeal of this
model is that, although still empirical in terms of speciﬁc mech-
anisms, it exhibits quasi-linear viscoelastic behavior in which the
static non-linear stress-strain behavior of the tissue is separable
from the dynamic non-linear behavior. Furthermore, the latter is
predicted to manifest as a power-law decay of stress with time
following a step increase in strain, as is observed experimentally
(Bates et al., 1994).
We have recently proposed a speciﬁc mechanism for the micro
yield events described above that derives from the Huxley-type
cross-bridge models of active ASM that are now well-established
(Mijailovich et al., 2000). Speciﬁcally, we have proposed that the
passive stress in ASM tissue is mediated by cross-linking proteins
that temporarily bind protein ﬁbers together within the tissue via
thermodynamically driven interactions (Donovan et al., 2010).
The cross-linkers extend from one ﬁlament and bind to attach-
ment sites on an adjacent ﬁlament, and can account for many
of the passive mechanical behaviors observed in ASMC such as
the responses to cyclic stretching and deep inspirations and ﬂu-
idization upon stretching. The cross-linker model also suggests
a compelling uniﬁcation between the mechanical mechanisms of
passive and active tissue; both involve cross-bridges, the only dif-
ference being that the binding probabilities in passive tissue are
symmetric functions of distance and are driven thermodynami-
cally while the binding probabilities in active tissue are asymmetric
and require the energy supplied by ATP (Donovan et al., 2010).
THE ORGAN SCALE
To this point we have described the balance of forces for a sin-
gle airway. However, the mechanical properties of the lung vary
signiﬁcantly along the airway tree. For example, the amounts of
collagen andASM in the airway wall progressively decrease toward
the periphery. In lung disease, it is also common that the prop-
erties of the airway wall and the parenchyma are altered, (e.g.,
airway remodeling associated with AHR). These regional passive
(mechanical and structural) and active (force-generating) het-
erogeneities have a major inﬂuence on the overall mechanical
behavior of the lungs. For example, when regions of the lung that
are connected in parallel becomemechanically disparate (so-called
“parallel heterogeneities”), the apparent overall resistance of the
lung, which normally has an inverse dependence on the frequency
of oscillatory ﬂow, decreases with frequency even more precipi-
tously. Conversely, for mechanically disparate regions of the lung
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that are connected in series, some of the oscillatory ﬂow can be
shunted into the proximal elastic compartment (e.g., the central
airways) which causes overall lung elastance to increase dramati-
cally with frequency. Thus, the crucial question is: how does the
function of the whole organ arise from the distributed nature of
structure and function at the level of the individual airways?
EXPERIMENTAL METHODS
The state-of-the-art method to assess the overall mechanical prop-
erties of the lung is based on themeasurement of input impedance.
A broad-band ﬂow perturbation is applied at the trachea while
pressure is measured at the same site. This is achieved with a
forced ﬂow oscillation technique. In mice, a computer-controlled
mechanical ventilator (Flexivent) can be used to apply and mea-
sure a controlled mechanical perturbation to the lungs at frequen-
cies of up to 20Hz or more (Schuessler and Bates, 1995). Although
technically less challenging due to the larger lung volume, the
approach is essentially the same for human subjects (Bates et al.,
2011). However, ﬂow perturbations in human subjects have to be
applied via the mouth rather than the trachea so some shunting
of ﬂow into cheeks and pharynx can inﬂuence the results related
to the lung.
The pressure [P(t )] and ﬂow signals [V ′(t )] are related in
the frequency domain by the relationship P(f)=Z (f)V ′(f), where
frequency (f) indicates the Fourier transform of the correspond-
ing function of time (t ). The complex function Z (f) is the input
impedance and is a model independent function that encapsulates
the mechanical properties of the lung. The physiological informa-
tion inferred frommeasurements of Z (f) dependson the frequency
range of the ﬂow oscillations applied to the lungs (Bates, 2009;
Bates et al., 2011). By ﬁtting physiologically motivated mathe-
matical models to Z (f), the model parameters can be determined
as measures of the physiological quantities they represent (Bates,
2009).
INCREASED LUNG IMPEDANCE ASSOCIATED WITH AHR
Using these approaches, Hantos et al. (1992) proposed a model
known as the constant-phase model. In this model, a uniformly
ventilated lung is accessed by single airway that has a Newtonian
resistance (Rn). This airway is coupled to a distal alveolar unit
composed of viscoelastic tissue that has mechanical impedance
with real and imaginary parts that have a constant ratio to each
other with frequency (i.e.,“constant-phase”). The dissipative com-
ponent,G, of this tissue impedance reﬂects the resistive properties
of the tissue, while the conservative component, H, is a measure
of tissue stiffness.
We have used the constant-phase model in studies of AHR in
mice to help identify the underlying mechanisms that are respon-
sible for exaggerated responses to methacholine. For example, in
BALB/c mice that were allergically sensitized to challenge with
ovalbumin,we found that AHR to a methacholine aerosol resulted
from a thickened epithelium and increased airway secretions, but
not from increased shortening of ASM (Wagers et al., 2004).
By contrast, when mice were treated with intra-tracheal cationic
protein, which has the effect of damaging the epithelium, mice
exhibited AHR characterized by increased ASM shortening (Bates
et al., 2006).When both mechanisms were present simultaneously,
mice were extremely hyperresponsive, arguably recapitulating the
essential features of a severe asthma attack (Bates et al., 2008).
However, when methacholine is administered via the peripheral
circulation rather than as an aerosol, the ASM exhibits increased
shortening relative to the control. We hypothesize that this exag-
gerated response to injection reﬂects an increased leakiness of
an inﬂamed pulmonary endothelium, allowing a greater dose of
methacholine to reach the ASM (Cojocaru et al., 2008). These
results highlight the important role that inﬂammation plays in
AHR. This role is well known in allergic asthma, which has been
shown to lead to alterations in the excitation-contraction cou-
pling behavior of ASM (Bjorck et al., 1992; Mitchell et al., 1994),
in addition to the biophysical roles alluded to above.
THE MULTI-SCALE MODEL OF THE LUNG
INTEGRATING ACROSS THE SCALES TO ACHIEVE A FULL LUNG MODEL
To scale up to the level of the lung from a model of a single airway,
we embed the conducting airway tree within a parenchymal tissue
continuum (Figure 12 – organ scale). The airway tree geometry is
generated using an asymmetrically branching, 3-D tree-generating
algorithm that aims to be morphometrically accurate (Tawhai
et al., 2004). There are several important reasons for scaling to a full
lung topology instead of only studying the behavior of a limited
number of airways. First, we can impose physiological boundary
conditions that are consistent with the environment and function
of the lung. Second, we can exploit medical lung imaging to create
subject-speciﬁc models in order to test the sensitivity of regional
bronchoconstriction to airway geometry. And third, it is only by
correctly accounting for the spatial distribution of the airway tree
within the lung parenchyma that the appropriate contribution of
regional differences in tissue expansion (due to gravity and normal
variability in material properties) can be assigned to the balance
of forces on the airway wall during its constriction.
To achieve computational feasibility when scaling the model
to represent an entire human lung (that contains about 60,000
bronchial airways), we assume each airway is radially symmetric
and that changes in airway mechanics during breathing are deter-
mined only by changes in radius and not length. At the tissue level,
each airway is comprised of an airwaywall and a surroundingASM
layer that interactsmechanicallywith the parenchyma (Figure 12 –
tissue scale). In this way, we calculate the active contractive force
generated by the ASM and the opposing passive mechanical forces
provided by airwaywall stiffness and outward parenchymal tether-
ing. From the resulting balance of all these forces,we candetermine
the airway radius; this calculation is repeated for each airway with
respect to time.
For computational simpliﬁcation, we initially considered an
arbitrary 3-D unit of lung tissue that is representative of the whole
lung and its airways (this includes a range of airway sizes). The
location of the unit is relatively unimportant for establishing an
initial understanding of the system behavior, but it can be scaled
to the whole lung and ﬁtted to the anatomically based geometry
of the full conducting airway tree – this is a question of computa-
tional rather than conceptual complexity. The tissue unit contains
all the key elements of the airways embedded in a parenchymal
continuum. The alveoli are not represented discretely, but are
assumed to operate as a smooth, homogeneousmaterial (as part of
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FIGURE 12 |The four spatial scales and their interactions in the
multi-scale lung and airway model.The four scales of organ, tissue, cell,
and molecule interact as follows: (A) anisotropic strain from the parenchymal
continuum model (organ scale), linearized to an expression for parenchymal
tethering, (B) Shortening velocity that is limited by the balance of active and
passive forces, (C) Coupling of calcium to force generation via activation of
MLCK, (D) Active and passive force generation from cross-bridges and
cross-linkers, (E) Airway constriction and redistribution of ventilation.
the organ scale parenchymal continuum) regardless of the airway
size or order. The airways included in the unit have eight orders
of branching (generated by a space-ﬁlling branching algorithm;
Tawhai et al., 2004). Again, for simpliﬁcation and scaling feasibil-
ity, each airway segment is assumed to be radially symmetric and
longitudinally stiff. Length changes are assumed independent of
radial changes.
We use a continuum approach to embed the airway tree
within “lung tissue” that is a compressible, hyper-elastic mater-
ial in 3-D (Tawhai et al., 2006, 2009). This “tissue” is essentially a
homogenization of the elastic properties of the parenchyma, air,
airways, and blood vessels. We assume material compressibility
because the tissue contains air that is free to move into or out of
the lung. Stress and strain are related by a strain energy density
function, and the response parameters of the tissue are selected
such that normal lung inﬂation pressures give rise to expected
expansion volumes for the tissue (Tawhai et al., 2009). By solv-
ing the governing equations of ﬁnite elasticity (large deformation)
mechanics using a ﬁnite element method, our model is capable of
simulating tissue deformation due to both gravity and the expan-
sion and recoil associated with cyclic changes in pressure on the
model surface due to breathing. Figure 12 (organ level) illustrates
a distribution of recoil pressures on a ﬁnite element model of the
right lung in the upright position under gravitational load. Due
to the inaccessibility of the lung tissue to direct measurement and
limitation of high resolution imaging of supine or prone postures,
data for the validation of the tissue mechanics model are lim-
ited (discussed later). However, we have validated the prediction
of the distribution of tissue density due to the model’s defor-
mation under gravity in the supine posture by comparing this
against imaging data of subjects in the same posture (Tawhai et al.,
2009). This model provides the boundary pressures and local elas-
tic properties of the parenchyma that are required for interaction
with the tissue level model. The airway lumen radii computed
at the tissue level depend on their coupling with the organ level
model, the non-linear properties of the airwaywall, andASM force
generation.
Each airway segment is classiﬁed according to its Horsﬁeld
order andhas three layerswithproperties that dependon theorder:
an inner wall layer that contributes passive stiffness, an active
ASM layer that generates force, and an outer parenchymal layer,
which serves as an interface with the parenchymal continuum that
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surrounds the lung segment, and mediates tethering (Figure 12 –
tissue scale). Airway diameter is a function of transmural pressure
generated by stress within the ASM layer, external forces acting via
the parenchyma,and luminal air pressure (Lambert et al., 1982). To
enable coupling across the tissue-organ scales, the model uses two
representations of the parenchyma: a local layer and the conditions
of the parenchymal continuum at the location of the airway. These
layers are connected with the material properties of the local layer
determined from a linearization of the anisotropic continuum at
the location of the airway (Figure 12). That is, the lung tissue will
have undergone local volumetric changes that depend on its loca-
tion in the lung; tissue in the gravitationally dependent regionswill
generally be under less tension than tissue in the non-dependent
regions, and the irregular curvilinear shape of the lung introduces
variability in the distribution of strain. Note that this variability
occurs independently of any assumptions of heterogeneity in the
intrinsic tissue properties.
Airway smooth muscle stress is generated by a cross-bridge
model of sliding ﬁlaments within the ASMCs (Figure 12 – mole-
cule scale) under the regulation of Ca2+ signaling (Figure 12 – cell
scale). The models deﬁning these processes were addressed in
detail earlier and are include in the whole lung model. Thus,
overall airway diameter is regulated by ASMC contraction act-
ing against parenchymal tethering which varies with gravity and
breathing.We consider breathing that is driven by changes in force
or displacement at the (pleural) surface of the model, as opposed
to positive pressure ventilation that is driven by increasing the
pressure at the mouth. We have therefore assumed that the air
pressure remains small relative to the parenchymal and ASMC
forces, and so does not make a signiﬁcant contribution to the
transmural pressure. This is in contrast to positive pressure mod-
els with ﬁxed tidal volume in which the air pressure can make a
signiﬁcant contribution (Venegas et al., 2005).
Coupling of all of these models and solving simultaneously for
each airway with respect to time is a signiﬁcant computational
problem. Not only must all models be solved simultaneously for
force balance, but a numerical continuation is also required (All-
gower and Georg, 2003) because of the bistability inherent in the
Lambert model of the pressure-radius relationship for the small
airways (Affonce and Lutchen,2006). It is this computational com-
plexity (i.e., modulating transitions between the two stable states
for each airway) whichmost limits the computational scope.How-
ever, the process is inherently parallel and potentially amenable to
parallel computing approaches.
MODEL OUTCOMES
It should be initially emphasized that the major outcome of this
multi-scale modeling is the ﬁrst working, biologically based in sil-
ico lung and the proof-of concept of the feasibility of this approach
(Politi et al., 2010). Although many aspects of lung physiology are
not yet included in the current model, their incorporation is now
more a function of time and experimentation rather than a major
modeling concept.
Reduced airway contraction due to breathing
Our simulations of breathing with contractile agonist exposure
demonstrated that, as expected, the extent of airway contraction
was a function of pressure changes induced by breathing imposed
on pressure changes induced by ASMC stress. Importantly, the
organ model also revealed the emergent behavior of increased
airway diameter associated with breathing as compared to static
conditions. Sensitivity analysis suggested this response was (again,
as expected from experimental work) a function of the ASMC
cross-bridge kinetics determined by the attachment and detach-
ment rates. However, the model also suggested that the maximal
isometric force and the rMLC dephosphorylation rate were also
important (Politi et al., 2010).
Although airway radius was increased by breathing, this
increase was smaller than that proposed from experimental stud-
ies (Politi et al., 2010). This raises interesting questions about the
signiﬁcance of the effect and the conditions under which it is
observed. Our model simulates tidal breathing rather than exper-
imental deep inspiration which appears to have a large relaxation
effect on ASMCs. More importantly, experimental approaches
often examine isolated ASM strips which alter or abolish the orga-
nization constraints of the airway and remove the multi-scale
interactions. Thus, a small change in airway diameter may be a
more realistic response. On the other hand, passive ASMC prop-
erties, which exhibit ﬂuidization responses, are not yet included
in the multi-scale model and these are expected to enhance the
magnitude of airway relaxation.
The importance of spatial heterogeneity at the cellular scale
Simulations at the scale of the individual ASMCs have shown that
the amount of force generated by the ASMCs is especially sensitive
to the spatial distributions of the Ca2+ responses (i.e., the shape
of the Ca2+ waves; Wang et al., 2008, 2010). Thus, unexpectedly,
overall airway contraction can be modiﬁed and controlled by rel-
atively minor and subtle changes in Ca2+ signaling at the cellular
scale.
The interplay between passive and active elements at the
molecular scale
At the molecular scale, passive elements such as cross-linkers
generate complex dynamic behavior, including ﬂuidization, adap-
tation, and velocity-dependent force generation (Donovan et al.,
2010).Hence,manyof themechanical properties of ASMCs are the
emergent result of these molecular scale interactions, and are thus
a blend of both active and passive processes. Tissue scale mechan-
ical behavior cannot be understood by considering cross-bridges
alone.
Slow transitions between open and closed airway states
A result which has emerged only from the coupling of multiple
scales in the model is a slow and steady transition between an
open and closed airway state, with the transition being modulated
by cross-bridge dynamics (Politi et al., 2010). It s well known
that bistability between open and closed states is an inherent
characteristic of the Lambert airway wall model (Lambert et al.,
1982; Affonce and Lutchen, 2006) but this static model allows
for instantaneous transitions between the open and closed state.
Only by coupling the tissue scale with the dynamics of the cross-
bridge model of ASMCs are these airway transitions modulated
into the slow and steady behavior seen experimentally (Latourelle
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et al., 2002; Oliver et al., 2007). This result cannot be obtained by
considering either scale in isolation.
Heterogeneity and gravitational gradients
Heterogeneity in airway constriction is an important aspect in the
manifestation of AHR and changes in ventilation and has been
explained by changes in dynamic factors as opposed to struc-
tural factors. Some studies suggest the constriction pattern can be
altered by deep inspiration while other studies suggest that clus-
tered ventilation occurs preferentially in gravitationally dependent
tissue (Venegas et al.,2005;Tgavalekos et al.,2007). The couplingof
non-linear sub-scale models in the multi-scale model allows us to
consider the degree of heterogeneity attributable to structural fac-
tors. A signiﬁcant gravitational gradient is developed, and airways
located in dependent tissue are exposed to parenchymal conditions
which differ signiﬁcantly (Politi et al., 2010). This suggests that
some heterogeneity, particularly that found in dependent tissue,
may be explained by structural phenomena; however, “resetting”
of the constriction pattern still requires a dynamic explanation.
Passive tissue ﬂuidization
One result which has the potential to signiﬁcantly impact the
dynamic equilibration of in vivo airways is strain-induced ﬂu-
idization of passive ASM. When exposed to oscillatory strain, the
force exerted by stretched, passive ASM is reduced. This reduction
in force is proportional to the strain oscillation amplitude, and
persists beyond a 30-s timescale; this occurs in both the experi-
mental and modeling results (Donovan et al., 2010). This has the
potential to reduced airway constriction due to tidal breathing
and/or deep inspirations (Ijpma and Lauzon, 2012).
FUTURE DIRECTIONS
We emphasize here that the multi-scale model is a work-in-
progress. Although there are a huge number of possible additions
to the model, we propose a series of questions and modiﬁcations
we consider to bemost important to our current sub-scalemodels.
AT THE MOLECULAR SCALE
How important is the latch-state in the long-term modulation of
force generation?
Can passive elements such as cross-linkers, independent of cross-
bridges, reproduce any of the behaviors traditionally thought to
be caused by the latch-state? This is question is closely related to
the question of how the active and passive elements interact to
control force generation in a single ASMC; the latch-state, being
in a half-way state between active and passive, will play a central
role in these investigations.
What happens if unphosphorylated myosin can bind to actin?
How will this inﬂuence AMSC stiffness as a function of time after
stimulation or stretching? How should this best be modeled?
Should an ASMC be modeled using a Huxley-style formation for the
cross-bridges and cross-linkers, or is a more continuous (a more
complicated) approach necessary?
Data indicate that breakage of cross-linkers and cross-bridges after
a large stretchplays an important role in decreasing the active force,
but such breakage has not yet been included in our models.
AT THE CELLULAR SCALE
How important are stochastic properties of Ca2+ release?
We have to develop a stochastic model of Ca2+ oscillations
and waves and determine whether the measured single channel
properties of the IP3R are sufﬁcient to generate the observed
behavior.
How do the patterns of Ca2+ waves and oscillations modulate force
generation?
Although we know that the shape of the Ca2+ oscillation plays a
role inmodulating force generation, and thus there is ameasurable
difference between the force generated by Ca2+ oscillations and
the force generated by Ca2+ waves, we need to develop mathemat-
ical methods that can take these differences into account without
greatly increasing the required computer time for simulations.
How will a human ASMC model differ from a mouse model?
As yet,we have only developed amousemodel.We need to develop
a detailed model of Ca2+ signaling in human ASMC. This will
require additional data from human tissues.
What are the effects of inﬂammation on force generation?
Inﬂammatory aspects of the Ca2+ signaling pathways and their
connection (for example) to Ca2+ inﬂux, need to be included in
the model so that we can study the effects of inﬂammation on
force generation.
What is the role of mechanotransduction in Ca2+ signaling in
ASMCs?
Are stretch-activated or compression-activated calcium channels
present? If so, how important are they? Can we use a model to
predict how important such channels would be expected to be?
AT THE TISSUE SCALE
How important are the interactions between active and passive
elements in force generation?
The passive adaptation of stress in lung tissue will change the
stress acting on actively cycling cross-bridges and thereby affect
their actin-binding probabilities. Conversely, active force genera-
tion within the ASM tissue will affect the stress bearing role of the
passive connective tissue via the cross-linker mechanism.
How important are regional tissue heterogeneities in
airway-parenchymal tethering?
So far, we have modeled the parenchyma as a homogeneous
isotropicmaterial,but this is far fromreality,particularly in asthma
that involves regional tissue remodeling. We have begun to simu-
late the parenchyma as heterogeneous networks of springs, some
of which may be stiffened to represent ﬁbrotic remodeling, in
order to determine how parenchymal tethering modulates airway
responsiveness.
How important is the complex rheology of lung tissue in
determining AHR?
We have also modeled airway-parenchymal interactions under the
assumption that the tissue is purely elastic, but we know it is
markedly viscoelastic. We would therefore expect that the inﬂa-
tion history of the lung to also affect the extent to which the
parenchyma is able to resist ASM contraction.
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AT THE ORGAN SCALE
Major assumptions and/or limitations in the model at the organ
level are our deﬁnition of the material law, neglecting the potential
inﬂuence of air pressure, weak coupling between the tissue and
organ level mechanical models, and limitations on data against
which we can validate the model function.
How important is surfactant dynamics to the regional tissue
elasticity?
Our continuum model combines the contributions of tissue elas-
ticity and surface forces into a single description of the elastic
behavior of the lung parenchyma, parameterized to the expected
pressure-volume relationship for an intact lung at only two vol-
umes (functional residual capacity and total lung capacity). This
approach has been shown to be satisfactory for simulating static
lung deformations in the supine posture in two human subjects,
however this single material law parameterization is likely to be
inadequate for representing the mechanics of individual subjects,
particularly those with chronic lung disease. We have treated the
lung tissue mechanics as a sequence of static deformations, but
in the dynamic lung the contribution of surfactant dynamics and
how this changes with stretch (Majumdar et al., 2011) may be
important in the force balances that inﬂuence emergent behavior.
Does airway pressure make a signiﬁcant contribution to the
balance of pressures in a breathing lung?
Our initial model has neglected the contribution of air pressure
to the balance of forces on the airway. However, other breathing
lung models driven by positive pressure inﬂation with ﬁxed tidal
volume have shown that the contribution of the air pressure can
be signiﬁcant (Venegas et al., 2005). We have recently developed
a model that couples the tissue deformation model to pressure
development and ﬂow distribution in the full airway tree (Swan
et al., 2012). This ventilation model is not yet a component of the
multi-scale model, however we can control the degree and loca-
tion of static bronchoconstriction in the model and evaluate the
redistribution of alveolar and luminal pressures, which the model
predicts are relatively modest. Figure 12 (organ scale) illustrates a
“patchy”ﬂow distribution in thismodel that results from the inter-
action of increased airway resistance (Figure 12E) and distributed
tissue compliance.
How do we introduce bi-directionality in tissue and airway
mechanics?
In our multi-scale model, the airways and parenchyma are not
tightly coupled. That is, while the balance of forces acting on each
airway includes input from the parenchymalmechanics, the defor-
mation of the airway, or its closure does not act in the opposite
direction to contribute to the balance of forces in the continuum
model. Over long times scales this could exhibit as changes in the
surface forces, as we have already described. This limitation in
existing models means that we do not yet understand the depen-
dence between local airway constriction and the cyclic pressures
of breathing that are transmitted throughout the lung tissue: it
is not clear whether airway-parenchymal interdependence will
act to further impede ﬂow or to maintain ﬂow to constricted
regions.
Can we deﬁne a new protocol for validating multi-scale models?
For single scale models that have been designed to test a hypoth-
esis, the model is considered validated (at least to some degree)
if it qualitatively and quantitatively predicts an independent set
of experimental data. While the components of these large-scale
physiome-type models are data driven, every component is not
amenable to independent validation against experiment. This is
partly due to limitations on the data that can be acquired for val-
idation, and partly because the intrinsic structural and functional
connections across the scales can rendermeaningless a“validation”
that is performed at a single scale or under non-physiological con-
ditions. It is important to emphasize that we have developed the
multi-scale model to have a strong biophysical basis: it is grounded
in physical conservation laws, and is constrained by physiological
and biological parameters. The model’s foundation in physical
laws means that we only rarely have to revisit our description of
the fundamental behavior of its components; rather, ourmodeling
iterations are usually a matter of revisiting the model’s parame-
terization, or our computational methods that allow us to couple
different scales. And operating within physiological constraints
considerably – and conveniently – reduces the range of parameters
that can be chosen for the model. These two considerations pro-
vide some assurance that themodel does not violate either physical
laws or physiological behaviors; this is necessary to demonstrate,
but it is not a sufﬁcient “validation.” At the level of the integrated
model we can say with conﬁdence that the model is predictive
of several emergent behaviors that are consistent with pulmonary
physiology and asthmatic pathophysiology. This is one impor-
tant and necessary validation, but it does not guarantee that each
model scale is realistic. Understanding uncertainties at each scale
in the model is therefore imperative to providing conﬁdence in its
integrated predictions.
There are uncertainties in the model parameterization, as well
as natural variability in material properties and anatomical geom-
etry in the population. Rather than implementing the multi-scale
model innumerous subjects and/or computing a stochastic variant
of the model, a more systematic approach can be taken to address
uncertainty and to provide conﬁdence in the model predictions.
That is, the nature of the model enables us to discover which
structural or functional aspects of the integrated system are most
critical in the development of bronchoconstriction. Conversely –
and just as important – we can identify which model components
our predictions are not sensitive to. The most straightforward
approach is to perform a sensitivity analysis: simulating whole
model bronchoconstriction during systematic variation in the
model parameters. This is a standard approach to address uncer-
tainty in model parameterization, but we are not aware of it being
used to address the contribution of airway topology to lung func-
tion. In terms of addressing population variability, this systematic
approach ismore useful than repeated analysis of multiple subjects
because we can control the nature and extent of the anatomical
variation and provide comment on how this contributes to local
force balance. For example, a subject-speciﬁc deﬁnition of the dis-
tribution of airway wall thickness and stiffness, and distribution of
ASMcell typewouldbedesirable for a truly subject-speciﬁcpredic-
tion of bronchoconstriction. New insight into how, e.g., localized
wall thickening impacts on regionalASM force development could
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be gained through pooling simulation data from (many) subject-
speciﬁc modeling studies, but this introduces similar uncertainty
to an experimental study. In contrast, a systematic sensitivity
analysis can distinguish between the contribution of airway wall
thickening and stiffening (which would not be separable experi-
mentally in the subject-speciﬁc analysis), the thresholds at which
they become signiﬁcant, and whether their regional distribution is
of importance in the development of localized ventilation defects.
Because our model is amenable to implementation in a test unit or
in the whole lung, we can test its emergent behavior at the whole
organ level against clinical data. Lutchen et al. (Tgavalekos et al.,
2003, 2005) have demonstrated the potential of this approach by
validating complex global-level model behavior against multiple
physiological measurements through their “image-function mod-
eling” approach. In their studies they chose to constrict airways
within imaged regions of ventilation defect, and – through trial
and error – ﬁt a constriction distribution throughout the conduct-
ing airway tree that gave realistic prediction of airway impedance.
We now have the opportunity to extend this approach, by predict-
ing the spatial distribution of airway closure, and validating the
integrative behavior of the model against measurements of inert
gas washout, oscillation mechanics, and gas exchange.
CONCLUSION
We focus here on developing a whole lung model to address the
phenomenon of AHR, a cardinal feature of asthma. This is a chal-
lenging task in its entity because the lung is a complex organ
within which qualitatively different behaviors manifest over an
enormous range of length and time scales. So far, our approach
has been to select what we consider to be the most important
levels of scale involved in the genesis of AHR, and to model
these phenomena at each level of scale separately before com-
bining the resulting sub-models into a global model that links
behaviors between scales. We have made considerable progress
by establishing the fundamental framework for an in silico lung
model that based on key experimental observations made at
the levels of the molecule, the cell, the tissue, and the whole
organ. Furthermore, at each level of scale these representations
are, for the most, based on biophysical mechanisms operative
at lower levels of scale, allowing us to trace the global response
of the lung, following challenge with ASM agonist, to processes
operative all the way down to the molecules involved in ASM
force generation. In the future, we anticipate that many other
aspects of lung physiology will be included and that the model
will be developed to the stage where it can be used to gain
further insight into the understanding of AHR and potential
therapies.
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